It’s clear the President-elect and members of Congress are intent on repealing and replacing the ACA, the specifics of which are still in development. However, it is likely that a potential replacement strategy could include punting health care reform to the states. One plausible way the incoming administration could accomplish this is by significantly relaxing … Read more
Liz Brings to Leavitt Partners Extensive Federal and State Health Care Policy and Strategy Experience. Salt Lake City, March 26, 2019 –Today, Leavitt Partners is proud to announce and welcome Elizabeth Wroe as a principal based in Washington, D.C. Liz will develop and manage complex, multi-sector alliances, and will advise and inform clients on the … Read more
As we noted in July, CMS declined Massachusetts’ Medicaid 1115 demonstration request to establish a closed formulary. The proposed program would have given Massachusetts the ability to exclude certain FDA-approved drugs from coverage and thereby given the state additional leverage in negotiating rebates. The state and drug manufacturers would have otherwise continued to be subject to the rest of … Read more
The Affordable Care Act turned Medicaid into America’s largest public health care coverage program. While the volume associated with this growing program created increasing opportunities for providers, health systems, health plans, and vendors, these same stakeholders shouldn’t write off opportunities in Medicaid now simply because of the change in direction at the federal level. Instead, … Read more
